or Try an Advanced Search...

    Technical Analysis for IMAB - I-Mab

    Grade Last Price % Change Price Change
    F 0.98 2.83% 0.03
    IMAB closed up 2.83 percent on Wednesday, November 20, 2024, on 37 percent of normal volume. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or bounces.
    1 Watcher
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent Down Down Down
    Historical IMAB trend table...
    Date Alert Name Type % Chg
    Jack-in-the-Box Bearish Bearish Swing Setup 0.00%
    Stochastic Buy Signal Bullish 0.00%
    Inside Day Range Contraction 0.00%
    Gapped Up Strength 0.00%
    Lower Bollinger Band Touch Weakness 0.00%
    Oversold Stochastic Weakness 0.00%
    New 52 Week Closing Low Bearish 2.83%
    Expansion Breakdown Bearish Swing Setup 2.83%
    New 52 Week Low Weakness 2.83%
    Down 3 Days in a Row Weakness 2.83%
    Older End-of-Day Signals for IMAB ...

       Recent Intraday Alerts

    Alert Time
    Possible Inside Day about 17 hours ago
    60 Minute Opening Range Breakout about 20 hours ago
    Up 3% about 20 hours ago
    1.5x Volume Pace about 21 hours ago
    Lower Bollinger Band Support about 21 hours ago
    View Earlier Intraday Alerts

    Get this analysis on your stocks daily!

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Track My Stocks
    Configure default chart indicators
    IMAB Chart by TradingView
    Basic chart:

    Profile

    I-Mab is a clinical stage biopharmaceutical company. It engages in discovering, developing and commercialization of differentiated biologics to treat diseases with significant unmet medical needs, particularly cancers and autoimmune disorders. The company was founded by Jingwu Zhang Zang on June 30, 2016 and is headquartered in Pudong, China.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Biotechnology Biopharmaceutical Cancer Life Sciences Disease Pharmacy Medication Autoimmune Disorders Immune Disorders

    Is IMAB a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Nov 17 I-Mab Third Quarter 2024 Earnings: US$0.25 loss per share (vs US$0.57 loss in 3Q 2023)
    Nov 14 I-Mab Biopharma GAAP EPS of -$0.11 misses by $0.04
    Nov 14 I-Mab Reports Third Quarter 2024 Results
    Nov 6 I-Mab names Sean Fu as CEO
    Nov 6 I-Mab Appoints Sean Fu, PhD, MBA, as Chief Executive Officer
    Oct 31 I-Mab to Release Q3 2024 Financial Results on November 14, 2024
    Oct 30 I-Mab to Present Givastomig Phase 1 Optimal Dose Estimation Data at SITC 2024
    Oct 28 I-Mab to Participate at the Truist Securities BioPharma Symposium
    Oct 25 I-Mab Biopharma’s Strategic US Transition and Pipeline Focus
    Oct 9 IMab (IMAB) Moves to Buy: Rationale Behind the Upgrade
    See more IMAB news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 2.5362
    52 Week Low 0.8989
    Average Volume 434,794
    200-Day Moving Average 1.51
    50-Day Moving Average 1.19
    20-Day Moving Average 1.09
    10-Day Moving Average 1.04
    Average True Range 0.09
    RSI (14) 36.71
    ADX 19.14
    +DI 12.36
    -DI 23.98
    Chandelier Exit (Long, 3 ATRs) 1.15
    Chandelier Exit (Short, 3 ATRs) 1.18
    Upper Bollinger Bands 1.22
    Lower Bollinger Band 0.95
    Percent B (%b) 0.1
    BandWidth 24.98
    MACD Line -0.07
    MACD Signal Line -0.06
    MACD Histogram -0.0114
    Fundamentals Value
    Market Cap 80.97 Million
    Num Shares 82.6 Million
    EPS -3.78
    Price-to-Earnings (P/E) Ratio -0.26
    Price-to-Sales 2.55
    Price-to-Book 0.42
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 1.10
    Resistance 3 (R3) 1.09 1.04 1.08
    Resistance 2 (R2) 1.04 1.01 1.04 1.07
    Resistance 1 (R1) 1.01 0.99 1.02 1.02 1.06
    Pivot Point 0.96 0.96 0.96 0.96 0.96
    Support 1 (S1) 0.93 0.93 0.94 0.94 0.90
    Support 2 (S2) 0.88 0.91 0.89 0.89
    Support 3 (S3) 0.85 0.88 0.88
    Support 4 (S4) 0.86